Neuropathic Pain Screening: Construct Validity in Patients With Sickle Cell Disease

Individuals with pain from sickle cell disease (SCD) are often treated for nociceptive pain, but recent findings indicate they may also have neuropathic pain. PAINReportIt, a computerized version of the McGill Pain Questionnaire, provides a potential subscale that is the summed number of selected neuropathic pain quality words (PR-NNP), but it lacks construct validity. The study purpose was to ascertain PR-NNP construct validity in adults with SCD and chronic pain. In an outpatient setting, 186 participants completed the PAINReportIt, Neuropathic Pain Symptom Inventory (NPSI), and Leeds Assessment for Neuropathic Symptoms and Signs (S-LANSS). PR-NNP was moderately correlated with NPSI (r = .33, p < .001) and S-LANSS (r = .40, p < .001). Regression analysis indicated that PR-NNP and pain intensity, but not a nociceptive pain subscale, were significant predictors of NPSI and S-LANSS. Findings support construct validity of PR-NNP, which may be useful as a screening tool for neuropathic pain in patients with SCD.

[1]  R. Fillingim,et al.  A QST‐based Pain Phenotype in Adults With Sickle Cell Disease: Sensitivity and Specificity of Quality Descriptors , 2020, Pain practice : the official journal of World Institute of Pain.

[2]  Z. Wang,et al.  Implementing the PAINRelieveIt Randomized Controlled Trial in Hospice Care: Mechanisms for Success and Meeting PCORI Methodology Standards , 2017, Western journal of nursing research.

[3]  Yingwei Yao,et al.  Pain Intensity and Misconceptions Among Hospice Patients With Cancer and Their Caregivers: Status After 2 Decades , 2017, The American journal of hospice & palliative care.

[4]  C. Xiao,et al.  CaMKII&agr; underlies spontaneous and evoked pain behaviors in Berkeley sickle cell transgenic mice , 2016, Pain.

[5]  Z. Wang,et al.  PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model. , 2016, The Journal of clinical investigation.

[6]  D. Amtmann,et al.  A PROMIS Measure of Neuropathic Pain Quality. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[7]  R. Fillingim,et al.  Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic Pain? , 2016, Pain practice : the official journal of World Institute of Pain.

[8]  J. Panepinto,et al.  Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature , 2015, Pediatric blood & cancer.

[9]  M. Bennett,et al.  The role of screening tools in diagnosing neuropathic pain. , 2014, Pain management.

[10]  C. Maier,et al.  MICROVASCULAR COMPLICATIONS — NEUROPATHY ( D ZIEGLER , SECTION EDITOR ) Neuropathic Pain : Is Quantitative Sensory Testing Helpful ? , 2012 .

[11]  C. Stucky,et al.  Sickle cell mice exhibit mechanical allodynia and enhanced responsiveness in light touch cutaneous mechanoreceptors , 2012, Molecular pain.

[12]  D. Wilkie,et al.  Presence of neuropathic pain as an underlying mechanism for pain associated with cold weather in patients with sickle cell disease. , 2011, Medical hypotheses.

[13]  Z. Wang,et al.  Neurobiological mechanisms of pain in sickle cell disease. , 2010, Hematology. American Society of Hematology. Education Program.

[14]  D. Simone,et al.  Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. , 2010, Blood.

[15]  D. Wilkie,et al.  Cognitive Testing of PAINReportIt in Adult African Americans With Sickle Cell Disease , 2010, Computers, informatics, nursing : CIN.

[16]  R. Treede,et al.  Quantitative sensory testing: a comprehensive protocol for clinical trials , 2006, European journal of pain.

[17]  Blair H. Smith,et al.  The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. , 2005, The journal of pain : official journal of the American Pain Society.

[18]  Jacques Fermanian,et al.  Development and validation of the Neuropathic Pain Symptom Inventory , 2004, Pain.

[19]  Stuart Farber,et al.  Developing a Computerized Data Collection and Decision Support System for Cancer Pain Management , 2003, Computers, informatics, nursing : CIN.

[20]  D. Cros,et al.  Quantitative sensory testing. , 2003, Physical medicine and rehabilitation clinics of North America.

[21]  Donna L Berry,et al.  Usability of a computerized PAINReportIt in the general public with pain and people with cancer pain. , 2003, Journal of pain and symptom management.

[22]  S. Ballas,et al.  Sickle cell pain: a critical reappraisal. , 1998, Blood.

[23]  J. Turner,et al.  A multi-center evaluation of the McGill Pain Questionnaire: results from more than 1700 chronic pain patients , 1992, Pain.

[24]  W. Holzemer,et al.  Use of the McGill Pain Questionnaire To Measure Pain: A Meta‐Analysis , 1990, Nursing research.

[25]  S. Morley,et al.  An experimental investigation of the construct validity of the McGill Pain Questionnaire , 1989, Pain.

[26]  R. Melzack.  The McGill Pain Questionnaire: Major properties and scoring methods , 1975, PAIN.

[27]  Y. Saunthararajah,et al.  Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease. , 2010, Journal of the National Medical Association.

[28]  L. Vlahos,et al.  Comparison of pain quality descriptors in cancer patients with nociceptive and neuropathic pain. , 2007, In vivo.

[29]  D. Sheskin.  The Pearson Product-Moment Correlation Coefficient , 2003 .